title: Deal watch: Genentech dives deeper into the next wave of cancer immunotherapies.
authors.forename: Sarah
authors.initials: S
authors.lastname: Crunkhorn
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic / Q000191:economics / Q000639:trends; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D004791:Enzyme Inhibitors / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000191:economics / Q000639:trends*; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology
chemical_list: D004791:Enzyme Inhibitors